Neovasc Inc (NVCN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Neovasc Inc (NVCN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6382
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart failure and death. Neovasc’ Neovasc reducer is used for the treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It has its operations in Canada and the US. Neovasc is headquartered in Richmond, British Columbia, Canada.

Neovasc Inc (NVCN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neovasc Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neovasc Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neovasc Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neovasc Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Neovasc Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neovasc Inc, Medical Equipment, Deal Details 10
Partnerships 10
Neovasc Enters into Licensing Agreement University of Pennsylvania 10
Equity Offering 11
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Debt Offering 16
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 16
Asset Transactions 17
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 17
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 18
Acquisition 20
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 20
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 22
Neovasc Inc – Key Competitors 23
Neovasc Inc – Key Employees 24
Neovasc Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 10, 2018: Neovasc Announces Results for the First Quarter 2018 26
Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 29
Nov 14, 2017: Neovasc Announces Results for the Third Quarter of 2017 32
Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 35
May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 38
Mar 23, 2017: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 40
Corporate Communications 43
Jun 11, 2018: Neovasc Appoints Steve Rubin as Chairman of the Board 43
Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 44
Legal and Regulatory 45
Nov 03, 2017: Neovasc Provides Litigation Update 45
Mar 10, 2017: Neovasc Announces TSX Symbol Change to NVCN 46
Jan 18, 2017: Neovasc Announces Update in Litigation with CardiAQ 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Neovasc Inc, Medical Equipment, Key Facts, 2017 2
Neovasc Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Neovasc Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neovasc Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neovasc Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neovasc Inc, Deals By Market, 2012 to YTD 2018 8
Neovasc Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neovasc Enters into Licensing Agreement University of Pennsylvania 10
Neovasc Raises USD37.5 Million in Public Offering of Units 11
Neovasc Raises USD75 Million in Public Offering of Shares 13
Neovasc Completes Public Offering Of Shares For US$22.7 Million 14
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 15
Neovasc Raises USD27.83 Million in Private Placement of Notes Due 2018 and Warrants 16
Boston Scientific Acquires Tissue Processing Technology and Facility from Neovasc for USD68 Million 17
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 18
Boston Scientific Acquires 15% Stake in Neovasc for USD7 Million 20
Fidelity Acquires 30% Stake in Neovasc from Peregrine Ventures 22
Neovasc Inc, Key Competitors 23
Neovasc Inc, Key Employees 24
Neovasc Inc, Subsidiaries 25

List of Figures
Neovasc Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Neovasc Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Neovasc Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Neovasc Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Neovasc Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neovasc Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Neovasc Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neovasc Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Neovasc Inc (NVCN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Venture Lighting International Inc:企業の戦略的SWOT分析
    Venture Lighting International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • University of Pittsburgh Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Pittsburgh Medical Center (UPMC) is a health care provider organization. It is a non-profit health care firm comprising a wide network of hospitals, clinics, and long-term care, rehabilitation and retirement facilities. The company offers several services such as commercial, me …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • aap Implantate AG (AAQ):企業の製品パイプライン分析2018
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • J. Lauritzen AS:石油・ガス:M&Aディール及び事業提携情報
    Summary J. Lauritzen AS (J. Lauritzen), a subsidiary of Lauritzen Fonden, is a shipping company that provides ocean transport services. The company operates a fleet of bulk carriers and gas carriers. Its bulk carriers include ocean transport services for dry bulk cargoes. J. Lauritzen provides marit …
  • Insulet Corp (PODD):企業の財務・戦略的SWOT分析
    Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem …
  • Atrion Corp (ATRI):企業の財務・戦略的SWOT分析
    Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Costcutter Supermarkets Group Limited:企業の戦略・SWOT・財務情報
    Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Robins & Morton LLC:企業の戦略・SWOT・財務情報
    Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report Summary Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Steris PLC:戦略・SWOT・企業財務分析
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization that provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinica …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Campofrio Food Group, S.A.:戦略・SWOT・企業財務分析
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Publicis Groupe SA:企業の戦略・SWOT・財務情報
    Publicis Groupe SA - Strategy, SWOT and Corporate Finance Report Summary Publicis Groupe SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sangamo Therapeutics Inc (SGMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆